These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3995080

  • 1. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD.
    Biochim Biophys Acta; 1985 May 29; 840(1):13-20. PubMed ID: 3995080
    [Abstract] [Full Text] [Related]

  • 2. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2753-7. PubMed ID: 3632704
    [Abstract] [Full Text] [Related]

  • 3. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH, Baars LG.
    Biochem Pharmacol; 1989 Apr 01; 38(7):1115-20. PubMed ID: 2706010
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats.
    MacNicoll AD, Nadian AK, Townsend MG.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1331-6. PubMed ID: 6712738
    [Abstract] [Full Text] [Related]

  • 5. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF, Preusch PC, Patterson JL, Suttie JW.
    Arch Biochem Biophys; 1984 Feb 01; 228(2):480-92. PubMed ID: 6696443
    [Abstract] [Full Text] [Related]

  • 6. Warfarin resistance in a Chicago strain of rats.
    Misenheimer TM, Suttie JW.
    Biochem Pharmacol; 1990 Nov 01; 40(9):2079-84. PubMed ID: 2242035
    [Abstract] [Full Text] [Related]

  • 7. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ, Hildebrandt EF, Suttie JW.
    J Biol Chem; 1982 Oct 10; 257(19):11210-2. PubMed ID: 6811577
    [Abstract] [Full Text] [Related]

  • 8. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM, Cai D, Wallin R.
    Biochem Pharmacol; 1998 Jan 15; 55(2):169-75. PubMed ID: 9448739
    [Abstract] [Full Text] [Related]

  • 9. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ, Principe LM, Walsh WA, Friedman PA.
    Biochemistry; 1983 Nov 22; 22(24):5655-60. PubMed ID: 6652076
    [Abstract] [Full Text] [Related]

  • 10. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC, Suttie JW.
    Arch Biochem Biophys; 1984 Nov 01; 234(2):405-12. PubMed ID: 6497379
    [Abstract] [Full Text] [Related]

  • 11. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ, Preusch PC, Hildebrandt E, Suttie JW.
    J Biol Chem; 1983 Apr 10; 258(7):4372-80. PubMed ID: 6833262
    [Abstract] [Full Text] [Related]

  • 12. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO, Wedlund PJ.
    Drug Metab Dispos; 1991 Apr 10; 19(1):278-9. PubMed ID: 1673414
    [No Abstract] [Full Text] [Related]

  • 13. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB.
    Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF, Suttie JW.
    Biochemistry; 1982 May 11; 21(10):2406-11. PubMed ID: 6807339
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of the coumarin anticoagulant targeted vitamin K epoxide reduction system. Study of kinetic parameters in susceptible and resistant mice (Mus musculus domesticus).
    Lasseur R, Grandemange A, Longin-Sauvageon C, Berny P, Benoit E.
    J Biochem Mol Toxicol; 2006 May 11; 20(5):221-9. PubMed ID: 17009238
    [Abstract] [Full Text] [Related]

  • 16. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH, Janssen YP, Vervoort LT.
    Biochem J; 1994 Jan 15; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [Abstract] [Full Text] [Related]

  • 17. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE, Preusch PC.
    Biochem Pharmacol; 1988 Mar 01; 37(5):929-34. PubMed ID: 3345202
    [Abstract] [Full Text] [Related]

  • 18. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ, Principe LM.
    J Biol Chem; 1982 May 10; 257(9):4894-901. PubMed ID: 7068669
    [Abstract] [Full Text] [Related]

  • 19. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA, Suttie JW.
    Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564
    [Abstract] [Full Text] [Related]

  • 20. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA, Thijssen HH, Vermeer C.
    Biochim Biophys Acta; 1986 Oct 29; 884(1):150-7. PubMed ID: 3490277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.